Search

This procedure aims to guide those involved in the use of Section 136 of the Mental Health Act 1983 (amended 2007) as to what action ought to be taken to meet the statutory requirements imposed by the legislation, and to promote good practice as laid down in the Code of Practice, specifically Chapter 16 in relation to police powers and places of safety.

To provide information to prescribers, registered nurses and medicines management staff to ensure that zuclopenthixol acetate injection (Clopixol Acuphase®) is prescribed, administered and monitored safely and effectively, as per national guidance and licensed indications, to adult patients in inpatient settings under the care of the Trust.

The objectives of this policy are to describe the standards expected and the supporting processes for the management of the Trust's waste streams in accordance with current legislation.

Safeguarding is everyone's business. Employees need to know the appropriate actions to take in order to protect and safeguard adults from abuse. This policy has been developed to describe the responsibilities of employees and organisation for the recognition and prevention of abuse and clarify the actions to take when abuse is suspected or identified.

This policy defines the framework to ensure the Trust meets its obligations in relation to the NHS Code of Confidentiality, Data Protection Act 2018, UK General Data Protection Regulation, Information Commissioner Officer's Code of Practice for Data Sharing.

This procedure describes the processes to enable the administration of non-Controlled Drug injectable medicines for patients attending the Treatment Room Service provided in Knowsley.

To provider guidance to staff to enable Mersey Care NHSFT to comply with the new Provider Selection Regime when procuring (or sub-contracting) relevent health care services, in line with relevent legislation and national guidance

This procedure provides guidance to ensure that valpoate treatment is appropriately and safely used in accordance with regulatory requirements for all female children and women of childbearing potential. It advises health care professionals of the actions to be taken to educate patients on safe use of valproate and ensure awareness of the potential risk of birth defects and congenital malformations associated with taking valproate in pregnancy.

This document clarifies the responsibility of Mersey Care NHS Foundation Trust clinicians and establishes the standards in respect of the management & decontamination of medical devices